Newman James W. Jr.
SEC CIK 1718364 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ADIL | ADIAL PHARMACEUTICALS, INC. | Dir | 20.0K | $95.8K | — | 3 | 2021-11-26 | 2021-12-30 |
Most active insiders at ADIL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Coastlands Capital LP | 10% | $106.3K | — |
| 2 | Shah Vinay | CFO | — | — |
| 3 | Davidson Matt | Chief Development Off, Dir | — | — |
| 4 | Gilliland Robertson H. | Dir | — | — |
| 5 | Schuyler Kevin | Dir | — | — |
| 6 | Goodman Tony | COO, Dir | — | — |
| 7 | Claiborne Cary J | CEO, Dir | — | — |
Newman James W. Jr. made no open-market trades at ADIL in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-03 | 2021-12-30 | ADIL | ADIAL PHARMACEUTICALS, INC. | Newman James W. Jr. | Dir | P - Purchase | $2.66 | +10.0K | 20.0K | +100% | +$26.6K | |
| MI | 2022-01-03 | 2021-12-30 | ADIL | ADIAL PHARMACEUTICALS, INC. | Newman James W. Jr. | Dir | P - Purchase | $2.71 | +15.0K | 34.6K | +76% | +$40.7K |
| I | 2021-11-30 | 2021-11-26 | ADIL | ADIAL PHARMACEUTICALS, INC. | Newman James W. Jr. | Dir | P - Purchase | $2.85 | +10.0K | 34.5K | +41% | +$28.5K |
Purchase Sale Sale after option exercise All abbreviations